SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-112202
Filing Date
2023-10-27
Accepted
2023-10-27 16:40:14
Documents
13
Period of Report
2023-10-25
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2329288d1_8k.htm   iXBRL 8-K 36686
2 EXHIBIT 3.1 tm2329288d1_ex3-1.htm EX-3.1 7829
  Complete submission text file 0001104659-23-112202.txt   221619

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA clrb-20231025.xsd EX-101.SCH 3018
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE clrb-20231025_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clrb-20231025_pre.xml EX-101.PRE 22361
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2329288d1_8k_htm.xml XML 3307
Mailing Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932 (608) 441-8120
Cellectar Biosciences, Inc. (Filer) CIK: 0001279704 (see all company filings)

IRS No.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36598 | Film No.: 231356054
SIC: 2834 Pharmaceutical Preparations